BACKGROUND
To describe the first reported case of toxic optic neuropathy secondary to docetaxel (Taxotere®) chemotherapy.
CASE PRESENTATION
A 53-year-old female presented with predominantly unilateral visual loss, but extensive bilateral visual field defects and bilateral optic nerve head swelling 2 weeks after first dose of docetaxel (Taxotere®) and trastuzumab (Herceptin®) chemotherapy for ...
